
Leupo 22.5mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Leuprolide (22.5mg)
Overview Leupo 22.5mg Injection
Leuprolide acetate 22.5mg injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy or irregular bleeding), uterine fibroids, and central precocious puberty (early onset puberty). Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include reduced libido, increased perspiration, tiredness, muscle weakness, and hot flushes. Prolonged use may weaken bones, necessitating calcium and vitamin D supplementation. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; persistent bleeding requires immediate medical attention. Prior to treatment, disclose any history of alcohol consumption, smoking, or osteoporosis. Inform your doctor of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Uses of Leupo 22.5mg Injection
Management of prostate carcinoma | Endometriosis care | Uterine fibroid management | Precocious puberty intervention
Major Benefits of Leupo 22.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Leupo 22.5mg Injection:
- Decreased libido
- Testicular atrophy
- Increased sweating
- Fatigue
- Muscle weakness
- Erectile dysfunction
- Hot flashes
How to use Leupo 22.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Leupo 22.5mg Injection works:
Leupo 22.5mg Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves suppressing testosterone levels in males. In females, it inhibits ovarian hormone synthesis, thus reducing estrogen levels and consequently menstruation.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Leupo 22.5mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Leupo 22.5mg Injection to pregnant individuals is strongly contraindicated. Pregnant women should consult their physician; research in animal and human subjects indicates substantial adverse fetal consequences.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Leupo 22.5mg Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administering Leupo 22.5mg Injection may induce adverse reactions impacting driving capabilities. Refrain from driving or operating equipment if drowsiness, dizziness, or visual impairment occurs during treatment with Leupo 22.5mg Injection.
KidneyCONSULT YOUR DOCTOR
Data regarding Leupo 22.5mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Leupo 22.5mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Leupo 22.5mg Injection :
Omit a Leupo 22.5mg Injection dose? Seek your physician's advice.
Facts to Know About Leupo 22.5mg Injection
Label | Value |
---|---|
Chemical Type | GnRH Agonist |
Developing Habits | No. |
Treatment Category | Obstetrics and Gynecology |